Zevenbergen Capital Investments LLC Acquires 4,511 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Zevenbergen Capital Investments LLC raised its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 0.9% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 517,777 shares of the biotechnology company's stock after purchasing an additional 4,511 shares during the quarter. Axon Enterprise accounts for approximately 3.1% of Zevenbergen Capital Investments LLC's holdings, making the stock its 10th biggest position. Zevenbergen Capital Investments LLC owned about 0.69% of Axon Enterprise worth $133,757,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. BKM Wealth Management LLC purchased a new position in shares of Axon Enterprise during the 4th quarter valued at about $32,000. Key Financial Inc increased its position in shares of Axon Enterprise by 367.6% during the 4th quarter. Key Financial Inc now owns 159 shares of the biotechnology company's stock valued at $41,000 after purchasing an additional 125 shares during the last quarter. Lindbrook Capital LLC increased its position in shares of Axon Enterprise by 43.3% during the 4th quarter. Lindbrook Capital LLC now owns 172 shares of the biotechnology company's stock valued at $44,000 after purchasing an additional 52 shares during the last quarter. Rakuten Securities Inc. bought a new position in shares of Axon Enterprise during the 4th quarter valued at approximately $48,000. Finally, Principal Securities Inc. bought a new position in shares of Axon Enterprise during the 4th quarter valued at approximately $49,000. 79.08% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several brokerages have commented on AXON. StockNews.com downgraded Axon Enterprise from a "buy" rating to a "hold" rating in a research report on Thursday, March 14th. JMP Securities reiterated a "market outperform" rating and issued a $375.00 target price on shares of Axon Enterprise in a research note on Tuesday, May 7th. The Goldman Sachs Group increased their target price on Axon Enterprise from $297.00 to $339.00 and gave the stock a "buy" rating in a research note on Wednesday, February 28th. JPMorgan Chase & Co. increased their target price on Axon Enterprise from $330.00 to $365.00 and gave the stock an "overweight" rating in a research note on Thursday, April 11th. Finally, Morgan Stanley increased their target price on Axon Enterprise from $285.00 to $310.00 and gave the stock an "equal weight" rating in a research note on Friday, April 26th. Two investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $335.27.

Insider Transactions at Axon Enterprise

In other news, insider Jeffrey C. Kunins sold 43,668 shares of the business's stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $309.94, for a total transaction of $13,534,459.92. Following the sale, the insider now owns 189,719 shares in the company, valued at $58,801,506.86. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, insider Jeffrey C. Kunins sold 43,668 shares of the company's stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $309.94, for a total value of $13,534,459.92. Following the sale, the insider now owns 189,719 shares in the company, valued at $58,801,506.86. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, President Joshua Isner sold 44,000 shares of the company's stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $309.96, for a total value of $13,638,240.00. Following the completion of the sale, the president now owns 275,843 shares in the company, valued at approximately $85,500,296.28. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 87,976 shares of company stock worth $27,268,201. Insiders own 6.10% of the company's stock.

Axon Enterprise Stock Down 0.6 %

Axon Enterprise stock traded down $1.65 during trading hours on Friday, reaching $288.79. The stock had a trading volume of 513,386 shares, compared to its average volume of 561,167. The company has a market cap of $21.79 billion, a price-to-earnings ratio of 84.44 and a beta of 0.91. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.91 and a quick ratio of 2.55. The business's 50 day moving average price is $308.48 and its 200-day moving average price is $271.91. Axon Enterprise, Inc. has a 52 week low of $175.37 and a 52 week high of $329.87.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its earnings results on Friday, May 10th. The biotechnology company reported $1.15 EPS for the quarter, topping analysts' consensus estimates of $0.95 by $0.20. Axon Enterprise had a net margin of 15.60% and a return on equity of 11.71%. The business had revenue of $460.74 million during the quarter, compared to the consensus estimate of $441.57 million. During the same period in the previous year, the company posted $0.51 earnings per share. The firm's revenue was up 34.3% on a year-over-year basis. Sell-side analysts anticipate that Axon Enterprise, Inc. will post 2.35 EPS for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.